Praxis Precision Medicines (NASDAQ:PRAX) Price Target Raised to $478.00 - Markets Daily

Praxis Precision Medicines ( NASDAQ:PRAX – Free Report ) had its price objective lifted by Royal Bank Of Canada from $462.00 to $478.00 in a research note released on Tuesday morning,Benzinga reports. The brokerage currently has an outperfo
Read more...